新型 NOX 抑制剂 2-乙酰吩噻嗪以依赖 GPVI 的方式损害胶原依赖性血栓形成。
The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner.
机构信息
Department of Pharmacy and Pharmacology, University of Bath, Bath Spa, UK.
出版信息
Br J Pharmacol. 2013 Jan;168(1):212-24. doi: 10.1111/j.1476-5381.2012.02130.x.
BACKGROUND AND PURPOSE
NADPH oxidases (NOXs) contribute to platelet activation by a largely unknown mechanism. Here, we studied the effect of the novel NOX inhibitor 2-acetylphenothiazine (2-APT) on human platelet functional responses and intracellular signaling pathways.
EXPERIMENTAL APPROACH
The generation of superoxide ions was assessed by single cell imaging on adhering platelets using dihydroethidium (DHE), while other reactive oxygen species (ROS) were detected with 5-(and-6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate (CM-H(2)-DCFDA). Whole blood thrombus formation, washed platelet aggregation, integrin αIIbβ3 inside-out signalling, Syk phosphorylation and PKC activation were analysed to understand the functional consequences of NOX inhibition by 2-APT in platelets.
KEY RESULTS
Superoxide ion generation stimulated by platelet adhesion on collagen and fibrinogen was significantly inhibited by 2-APT in concentration-dependent manner (IC(50) = 306 nM and 227 nM, respectively), whereas cumulative ROS accumulation was not affected by this pharmacological agent. 2-APT also abolished collagen-dependent whole blood thrombus formation and washed platelet aggregation in response to collagen but not thrombin. The activation of integrin αIIbβ3 and PKC in response to the GPVI-specific agonist collagen-related peptide (CRP) was significantly reduced, whereas the same responses to thrombin were not significantly affected by 2-APT. Finally, Syk activation in response to collagen but not thrombin was inhibited by 2-APT.
CONCLUSIONS AND IMPLICATIONS
Taken together, our results suggest that 2-APT attenuates GPVI-specific signalling and is a novel inhibitor of collagen-induced platelet responses. Therefore, NOXs could represent a novel target for the discovery of anti-thrombotic drugs.
背景与目的
NADPH 氧化酶(NOXs)通过一种尚未完全了解的机制促进血小板活化。在此,我们研究了新型 NOX 抑制剂 2-乙酰吩噻嗪(2-APT)对人血小板功能反应和细胞内信号通路的影响。
实验方法
通过用二氢乙啶(DHE)对黏附血小板进行单细胞成像,评估超氧阴离子的生成,而用 5-(和 6-)-羧基-2',7'-二氯二氢荧光素二乙酸酯(CM-H2-DCFDA)检测其他活性氧(ROS)。分析全血血栓形成、洗涤血小板聚集、整合素 αIIbβ3 内外信号转导、Syk 磷酸化和 PKC 激活,以了解 2-APT 对血小板中 NOX 抑制的功能后果。
主要结果
2-APT 以浓度依赖性方式显著抑制血小板黏附在胶原和纤维蛋白原上诱导的超氧阴离子生成(IC50 分别为 306 nM 和 227 nM),而这种药物对累积 ROS 积累没有影响。2-APT 还消除了胶原依赖性全血血栓形成和胶原诱导的洗涤血小板聚集,但对凝血酶无反应。胶原相关肽(CRP)作为 GPVI 特异性激动剂诱导的整合素 αIIbβ3 和 PKC 激活显著减少,而 2-APT 对凝血酶的相同反应没有显著影响。最后,2-APT 抑制了胶原但不是凝血酶诱导的 Syk 激活。
结论和意义
综上所述,我们的结果表明 2-APT 减弱了 GPVI 特异性信号转导,是胶原诱导血小板反应的新型抑制剂。因此,NOX 可能成为抗血栓药物发现的新靶点。